After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IGMS belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of IGM Biosciences Inc is $79.95M. A total of 0.57 million shares were traded on the day, compared to an average of 172.86K shares.
In the most recent transaction, Weber Steven sold 1,865 shares of IGMS for 1.12 per share on May 14 ’25. After the transaction, the PRINCIPAL ACCOUNTING OFFICER now owns 27,016 company shares. In a previous transaction on Mar 14 ’25, Weber Steven sold 1,701 shares at 1.23 per share. IGMS shares that PRINCIPAL ACCOUNTING OFFICER owns now total 28,881.
Among the insiders who sold shares, Tahir Misbah disposed of 7,329 shares on Mar 14 ’25 at a per-share price of $1.23. This resulted in the CHIEF FINANCIAL OFFICER holding 180,324 shares of IGMS after the transaction. In another insider transaction, Harler Mary Beth sold 7,329 shares at $1.23 per share on Mar 14 ’25. Company shares held by the Chief Executive Officer now total 339,703.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IGMS has a high of $22.50 and a low of $0.92.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IGMS’s latest balance sheet shows that the firm has $229.54M in Cash & Short Term Investments as of fiscal 2021. There were $28.76M in debt and $27.78M in liabilities at the time. Its Book Value Per Share was $0.01, while its Total Shareholder’s Equity was $244.91M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IGMS is Buy with a score of 2.86.
